SEC Form 4 · accession 0001628280-17-000754
SCYNEXIS INC · SCYX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gonzalez David Angulo
Officer — Chief Medical Officer
Period of report
Jan 31, 2017
Accepted (ET)
Feb 2, 2017 · 2:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178253
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.02 | Jan 31, 2017 | A | 140,000 | A | — | Jan 31, 2027 | Common Stock | 140,000 | 140,000 | D |
Explanation of responses
- F12.08% of the shares subject to the option vest monthly for 48 months as measured from the date of grant.